A. M. Zvonok - Concepedia

Author

A. M. Zvonok

Also Known As

A M Zvonok, A Zvonok, A. M. ZVONOK, A. M. Zvonok, A. Zvonok, A.M. Zvonok, Alexander M Zvonok, Alexander M. Zvonok, Alexander Zvonok

101

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Northeastern University University of Georgia Indiana University Bloomington University of Connecticut Boston University

About

A. M. Zvonok is an author at Northeastern University specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	436
2	Social Sciences	3	3	190
3	Health Sciences	2	2	70
4	Biochemistry	2	2	111
5	Immunology	1	1	31

A. M. Zvonok

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Activation of CB <sub>2</sub> cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS Mohab Ibrahim, Hongfeng Deng, A. M. Zvonok, Proceedings of the National Academy of Sciences	2003	484
Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin Andrea G. Hohmann, Jesse N. Farthing, A. M. Zvonok, Journal of Pharmacology and Experimental Therapeutics	2004	121
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats Elizabeth J. Rahn, A. M. Zvonok, Ganesh A. Thakur, Journal of Pharmacology and Experimental Therapeutics	2008	113
Activation of Cannabinoid CB<sub>2</sub>Receptors Suppresses C-Fiber Responses and Windup in Spinal Wide Dynamic Range Neurons in the Absence and Presence of Inflammation Andrea G. Nackley, A. M. Zvonok, Alexandros Makriyannis, Journal of Neurophysiology Pain MedicineMolecular PainCannabinoid PharmacologySocial SciencesPeripheral Edema	2004	110
Activation of peripheral cannabinoid CB<sub>1</sub>and CB<sub>2</sub>receptors suppresses the maintenance of inflammatory nociception: a comparative analysis T. Gutierrez, Jesse N. Farthing, A. M. Zvonok, British Journal of Pharmacology	2006	105
Ligand-Binding Architecture of Human CB2 Cannabinoid Receptor: Evidence for Receptor Subtype-Specific Binding Motif and Modeling GPCR Activation Ying Pei, Richard W. Mercier, Jenine K. Anday, Chemistry & Biology Cannabis UseBiochemistryG Protein-coupled ReceptorMedicineFunctional Selectivity	2008	100
Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist Terry Luk, Wenzhen Jin, A. M. Zvonok, British Journal of Pharmacology	2004	97
The cannabinoid <scp>CB</scp><sub>2</sub> receptor agonist <scp>AM</scp>1241 enhances neurogenesis in <scp>GFAP</scp>/<scp>G</scp>p120 transgenic mice displaying deficits in neurogenesis Hava Avraham, Shuxian Jiang, Yigong Fu, British Journal of Pharmacology	2013	78
Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain Tannia Gutierrez, Jonathon D. Crystal, A. M. Zvonok, Pain	2011	71
Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking Islam Gamaleddin, A. M. Zvonok, Alexandros Makriyannis, PLoS ONE Nicotine AddictionCannabinoid PharmacologySocial SciencesSubstance Use RecoveryMolecular Pharmacology	2012	65

Page 1